Published in Neuropsychopharmacology on April 24, 2015
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome. Schizophr Bull (2015) 0.79
The early identification of psychosis: can lessons be learnt from cardiac stress testing? Psychopharmacology (Berl) (2015) 0.75
Endocannabinoid Signaling Regulates Sleep Stability. PLoS One (2016) 0.75
Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats. PLoS One (2017) 0.75
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol (2017) 0.75
Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93
EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods (2004) 34.47
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature (2009) 10.79
Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature (1995) 6.33
Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci (2010) 5.70
Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev (2010) 5.24
Mechanisms of gamma oscillations in the hippocampus of the behaving rat. Neuron (2003) 5.17
Stimulus specificity of phase-locked and non-phase-locked 40 Hz visual responses in human. J Neurosci (1996) 4.68
Mechanisms of gamma oscillations. Annu Rev Neurosci (2012) 4.58
Endocannabinoid signaling in the brain. Science (2002) 4.28
Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry (1999) 3.74
The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl (1989) 3.61
Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci (2003) 3.45
EMG contamination of EEG: spectral and topographical characteristics. Clin Neurophysiol (2003) 3.12
The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull (2008) 3.09
Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci (2006) 3.09
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology (2004) 2.87
Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci (2006) 2.81
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull (2008) 2.81
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci (2000) 2.69
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci (2006) 2.66
Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci (2010) 2.56
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci (2005) 2.32
Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo. J Neurosci (2007) 2.31
Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol Psychiatry (2006) 2.25
Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett (2010) 2.24
Problems with the medicalization of marijuana. JAMA (2014) 2.13
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry (2011) 2.03
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature (2004) 1.92
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. Eur J Neurosci (2010) 1.77
Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry (2008) 1.75
Physicians and medical marijuana. Am J Psychiatry (2012) 1.72
Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology (2011) 1.57
Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav (2005) 1.49
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology (2008) 1.49
Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci (2009) 1.47
Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol (1982) 1.41
Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci (2006) 1.40
Canonical correlation analysis applied to remove muscle artifacts from the electroencephalogram. IEEE Trans Biomed Eng (2006) 1.37
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med (2009) 1.36
Gamma activity in schizophrenia: evidence of impaired network binding? Clin Neurophysiol (2000) 1.33
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol (2007) 1.30
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry (2008) 1.30
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience (2000) 1.25
Steady state and induced auditory gamma deficits in schizophrenia. Neuroimage (2009) 1.24
Cortical basket cell dysfunction in schizophrenia. J Physiol (2012) 1.22
Functional characteristics of parvalbumin- and cholecystokinin-expressing basket cells. J Physiol (2012) 1.19
Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry (2014) 1.14
Neurosystems: brain rhythms and cognitive processing. Eur J Neurosci (2013) 1.13
Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience (2010) 1.10
Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells. J Physiol (2011) 1.07
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl) (2008) 1.03
Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans. Neuropsychopharmacology (2012) 1.01
High-frequency oscillations and the neurobiology of schizophrenia. Dialogues Clin Neurosci (2013) 0.99
Spice: a legal marijuana equivalent. Mil Med (2011) 0.98
Insights into cortical oscillations arising from optogenetic studies. Biol Psychiatry (2012) 0.98
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy. Am J Psychiatry (2006) 0.95
The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories. Psychopharmacology (Berl) (2011) 0.92
The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology (Berl) (2008) 0.91
Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony. Proc Natl Acad Sci U S A (2012) 0.90
Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology (Berl) (2008) 0.89
Diversity beyond variance: modulation of firing rates and network coherence by GABAergic subpopulations. Eur J Neurosci (2004) 0.86
Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells. J Physiol (2012) 0.85
The effect of chronic cannabinoids on broadband EEG neural oscillations in humans. Neuropsychopharmacology (2012) 0.85
Converging evidence for gamma synchrony deficits in schizophrenia. Suppl Clin Neurophysiol (2013) 0.81
Modulation of network oscillatory activity and GABAergic synaptic transmission by CB1 cannabinoid receptors in the rat medial entorhinal cortex. Neural Plast (2008) 0.80